Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell therapies in the confirmatory cohort (N=22) and with ...
The new ingredient is positioned as an ‘insurance policy’ against cocoa supply chain volatility and says the bio-identical ingredient could stabilize supply as climate change strains traditional crops ...
Splinter Cell: Deathwatch is streaming now on Netflix. For people who decide to give Splinter Cell: Deathwatch a try on Netflix that are unfamiliar with Sam Fisher’s long and incredible run in the ...
In the age where video game adaptations are finally being given the justice and due diligence they deserve, Netflix has practically had the market cornered when it comes to animation. With a long list ...
Bodies keep surfacing — and so do questions. There's a dark current in Houston's bayous this year, with 16 bodies recovered, five of them in the same week last month. City leaders are downplaying ...
Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.
Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...
If you've spent any amount of time wandering through the stranger corners of the Internet, be it Reddit, 4Chan, or conspiracy-themed YouTube channels, you may have bumped into a phrase that sounds ...